These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3471527)

  • 1. Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycin.
    Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Mechl Z; Nekulova M; Kolariĉ K; Tomek R; Röthig J
    Eur J Haematol Suppl; 1987; 47():67-9. PubMed ID: 3471527
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Raney M; Logan T
    Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
    [No Abstract]   [Full Text] [Related]  

  • 3. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
    Kumai K; Kubota T; Ishibiki K; Abe O
    Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
    Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
    Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.
    Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Benavides M; Lotz JP; Misset JL; de Vassal F; Tapiero H
    Eur J Haematol Suppl; 1987; 47():33-42. PubMed ID: 3471523
    [No Abstract]   [Full Text] [Related]  

  • 7. Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial.
    Evensen SA; Wisløff F; Müller E; Talstad I; Waage A; Johansen L
    Eur J Haematol Suppl; 1987; 47():43-7. PubMed ID: 3471524
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pilot studies with aclacinomycin in patients with breast cancer or gastrointestinal tumors].
    Rainer H; Gössinger H; Lenzhofer R; Moser K; Schneeweiss B
    Wien Med Wochenschr; 1983; 133(7):183-7. PubMed ID: 6868630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) Study.
    Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Fäller K; Mechl Z; Nekulova M; Kolaric K; Tomek R
    Oncology; 1987; 44(3):159-63. PubMed ID: 3474571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of aclacinomycin-A (NSC-208734) in adenocarcinoma of the kidney.
    Decker DA; Drelichman A; Opipari MI; Al-Sarraf M
    Am J Clin Oncol; 1984 Oct; 7(5):527-8. PubMed ID: 6594927
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase II study of aclacinomycin A in acute leukemia in adults.
    Yamada K; Nakamura T; Tsuruo T; Kitahara T; Maekawa T; Uzaka Y; Kurita S; Masaoka T; Takaku F; Hirota Y; Amaki I; Osamura S; Ito M; Nakano N; Oguro M; Inagaki J; Onozawa K
    Cancer Treat Rev; 1980 Dec; 7(4):177-82. PubMed ID: 6938305
    [No Abstract]   [Full Text] [Related]  

  • 14. Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias.
    Mitrou PS
    Eur J Haematol Suppl; 1987; 47():59-66. PubMed ID: 3471526
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1980; 74():207-16. PubMed ID: 7003659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
    Gockerman JP; Silberman H; Bartolucci AA
    Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of aclarubicin in acute myeloblastic leukemia.
    Case DC; Ervin TJ; Boyd MA; Bove LG; Sonneborn HL; Paul SD
    Am J Clin Oncol; 1987 Dec; 10(6):523-6. PubMed ID: 3479891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial.
    Bertrand M; Multhauf P; Bartolucci A; Ellison D; Gockerman J
    Cancer Treat Rep; 1985 Jun; 69(6):725-6. PubMed ID: 3860295
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma.
    Martino S; Decker DA; Hynes HE; Kresge CL
    Invest New Drugs; 1987 Dec; 5(4):373-4. PubMed ID: 3481362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.
    Forastiere AA; Budman DR; Richards F; Aisner J; Weinberg V; Wood WC
    Cancer Treat Rep; 1983 Dec; 67(12):1137-8. PubMed ID: 6580949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.